Chengdu Gas Group Corporation Ltd. (SHA:603053)

Verve Therapeutics Revenue

Chengdu Gas Group Corporation had revenue of 1.15B CNY in the quarter ending June 30, 2025, with 11.58% growth. This brings the company's revenue in the last twelve months to 5.37B, up 3.55% year-over-year. In the year 2024, Chengdu Gas Group Corporation had annual revenue of 5.27B with 1.95% growth.

• Revenue (ttm): 5.37B
• Revenue Growth: +3.55%
• P/S Ratio: 1.59
• Revenue / Employee: 2.10M
• Employees: 2,560
• Market Cap: 8.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.27B	100.91M	1.95%
Dec 31, 2023	5.17B	337.38M	6.98%
Dec 31, 2022	4.84B	453.96M	10.36%
Dec 31, 2021	4.38B	213.49M	5.12%
Dec 31, 2020	4.17B	-650.54M	-13.50%